Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover

Tissue Engineering

Volumn 11, Issue 3-4, 2005, Pages 645-658

  Cowan, Catherine M ^a,b   Aalami, Oliver O ^a   Shi, Yun Ying ^a   Chou, Yu Fen ^b   Mari, Carina ^a   Thomas, Romy ^a   Quarto, Natalin ^a   Nacamuli, Randall P ^a   Contag, Christopher H ^a   Wu, Benjamin ^b   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; CELLS; PROTEINS; SURGERY; TISSUE CULTURE;

ADIPOSE-DERIVED STROMAL CELLS; CRANIOFACIAL DEFECTS; OSTEOGENESIS; RETIONIC ACID;

BONE;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BONE MORPHOGENETIC PROTEIN 2; CALCITONIN RECEPTOR; RETINOIC ACID;

ARTICLE; BONE DEVELOPMENT; BONE TURNOVER; CALVARIA; CELL CULTURE; CELL DIFFERENTIATION; CELL VIABILITY; ENZYME ACTIVITY; HISTOLOGY; IMAGING SYSTEM; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MESENCHYME CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; STAINING; STROMA CELL;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REMODELING; CELL SURVIVAL; CRANIOFACIAL ABNORMALITIES; MALE; MICE; MULTIPOTENT STEM CELLS; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; TRETINOIN;

EID: 20944437444     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2005.11.645     Document Type: Article

References (54)

1. Aalami, O.O., Nacamuli, R.P., Lenton, K.A., Cowan, C.M., Fang, T.D., Fong, K.D., Shi, Y., Song, H.M., Sahar, D.E., and Longaker, M.T. Applications of a mouse model of calvarial healing: Differences in regenerative abilities of juveniles and adults. Plast. Reconstr. Surg. 114, 713, 2004.
2. Cowan, C.M., Shi, Y.Y., Aalami, O.O., Chou, Y.F., Mari, C., Thomas, R., Quarto, N., Contag, C.H., Wu, B., and Longaker, M.T. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat. Biotechnol. 22, 560, 2004.
3. Halvorsen, Y.D., Franklin, D., Bond, A.L., Hitt, D.C., Auchter, C., Boskey, A.L., Paschalis, E.P., Wilkison, W.O., and Gimble, J.M. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng. 7, 729, 2001.
4. Tholpady, S.S., Katz, A.J., and Ogle, R.C. Mesenchymal stem cells from rat visceral fat exhibit multipotential differentiation in vitro. Anat. Rec. 272A, 398, 2003.
5. Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Benhaim, P., Lorenz, H.P., and Hedrick, M.H. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 7, 211, 2001.
6. Zuk, P.A., Zhu, M., Ashjian, P., De Ugarte, D.A., Huang, J.I., Mizuno, H., Alfonso, Z.C., Fraser, J.K., Benhaim, P., and Hedrick, M.H. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13, 4279, 2002.
7. Mizuno, H., Zuk, P.A., Zhu, M., Lorenz, H.P., Benhaim, P., and Hedrick, M.H. Myogenic differentiation by human processed lipoaspirate cells. Plast. Reconstr. Surg. 109, 199, 2002.
8. Ashjian, P.H., Elbarbary, A.S., Edmonds, B., DeUgarte, D., Zhu, M., Zuk, P.A., Lorenz, H.P., Benhaim, P., and Hedrick, M.H. In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast. Reconstr. Surg. 111, 1922, 2003.
9. Justesen, J., Pedersen, S.B., Stenderup, K., and Kassem, M. Subcutaneous adipocytes can differentiate into bone-forming cells in vitro and in vivo. Tissue Eng. 10, 381, 2004.
10. Frazza, E.J., and Schmitt, E.E. A new absorbable suture. J. Biomed. Mater. Res. 5, 43, 1971.
11. Peng, H., Wright, V., Usas, A., Gearhart, B., Shen, H.C., Cummins, J., and Huard, J. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J. Clin. Invest. 110, 751, 2002.
12. Wright, V., Peng, H., Usas, A., Young, B., Gearhart, B., Cummins, J., and Huard, J. BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol. Ther. 6, 169, 2002.
13. Lee, J.Y., Musgrave, D., Pelinkovic, D., Fukushima, K., Cummins, J., Usas, A., Robbins, P., Fu, F.H., and Huard, J. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J. Bone Joint Surg. Am. 83-A, 1032, 2001.
14. Loty, C., Sautier, J.M., Boulekbache, H., Kokubo, T., Kim, H.M., and Forest, N. In vitro bone formation on a bone-like apatite layer prepared by a biomimetic process on a bioactive glass-ceramic. J. Biomed. Mater. Res. 49, 423, 2000.
15. Reddi, A. Bioceramics, cells and signals in tissue engineering. In: Bioceramics: Proceedings of the International Symposium on Ceramics in Medicine, 11, 9, 1998.
16. Muller-Mai, C.M., Stupp, S.I., Voigt, C., and Gross, U. Nanoapatite and organoapatite implants in bone: Histology and ultrastructure of the interface. J. Biomed. Mater. Res. 29, 9, 1995.
17. Bench, L.L. Bioceramics. J. Am. Ceramic Soc. 81, 1705, 1998.
18. Krebsbach, P.H., Mankani, M.H., Satomura, K., Kuznetsov, S.A., and Robey, P.G. Repair of craniotomy defects using bone marrow stromal cells. Transplantation 66, 1272, 1998.
19. Goldstein, J.A. The use of bioresorbable material in craniofacial surgery. Clin. Plast. Surg. 28, 653, 2001.
20. Wozney, J.M., and Rosen, V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin. Orthop. 346, 26, 1998.
21. Harland, R.M. The transforming growth factor β family and induction of the vertebrate mesoderm: Bone morphogenetic proteins are ventral inducers. Proc. Natl. Acad. Sci. U.S.A. 91, 10243, 1994.
22. Hollinger, J.O., Schmitt, J.M., Buck, D.C., Shannon, R., Joh, S.P., Zegzula, H.D., and Wozney, J. Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. J. Biomed. Mater. Res. 43, 356, 1998.
23. Gazit, D., Ebner, R., Kahn, A.J., and Derynck, R. Modulation of expression and cell surface binding of members of the transforming growth factor-β superfamily during retinoic acid-induced osteoblastic differentiation of multi-potential mesenchymal cells. Mol. Endocrinol. 7, 189, 1993.
24. Leboy, P.S., Beresford, J.N., Devlin, C., and Owen, M.E. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures. J. Cell. Physiol. 146, 370, 1991.
25. Buttery, L.D., Bourne, S., Xynos, J.D., Wood, H., Hughes, F.J., Hughes, S.P., Episkopou, V., and Polak, J.M. Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng. 7, 89, 2001.
26. Bland, R., Sammons, R.L., Sheppard, M.C., and Williams, G.R. Thyroid hormone, vitamin D and retinoid receptor expression and signalling in primary cultures of rat osteoblastic and immortalised osteosarcoma cells. J. Endocrinol. 154, 63, 1997.
27. Ogston, N., Harrison, A.J., Cheung, H.F., Ashton, B.A., and Hampson, G. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics. Steroids 67, 895, 2002.
28. Skillington, J., Choy, L., and Derynck, R. Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J. Cell Biol. 159, 135, 2002.
29. Spector, J.A., Greenwald, J.A., Warren, S.M., Bouletreau, P.J., Crisera, F.E., Mehrara, B.J., and Longaker, M.T. Coculture of osteoblasts with immature dural cells causes an increased rate and degree of osteoblast differentiation. Plast. Reconstr. Surg. 109, 631, 2002.
30. Cowan, C.M., Quarto, N., Warren, S.M., Salim, A., and Longaker, M.T. Age-related changes in the biomolecular mechanisms of calvarial osteoblast biology affect fibroblast growth factor-2 signaling and osteogenesis. J. Biol. Chem. 278, 32005, 2003.
31. Zamurovic, N., Cappellen, D., Rohner, D., and Susa, M. Coordinated activation of Notch, Wnt and TGF-β signaling pathways in BMP-2 induced osteogenesis: Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J. Biol. Chem. 279, 37704, 2004.
32. Wiedmann-Al-Ahmad, M., Gutwald, R., Lauer, G., Hubner, U., and Schmelzeisen, R. How to optimize seeding and culturing of human osteoblast-like cells on various biomaterials. Biomaterials 23, 3319, 2002.
33. Gregory, C.A., Singh, H., Perry, A.S., and Prockop, D.J. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J. Biol. Chem. 278, 28067, 2003.
34. Prockop, D.J., Gregory, C.A., and Spees, J.L. One strategy for cell and gene therapy: Harnessing the power of adult stem cells to repair tissues. Proc. Natl. Acad. Sci. U.S.A. 100(Suppl. 1), 11917, 2003.
35. Franceschi, R.T., and Iyer, B.S. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J. Bone Miner Res. 7, 235, 1992.
36. Chentoufi, J., Hott, M., Lamblin, D., Buc-Caron, M.H., Marie, P.J., and Kellermann, O. Kinetics of in vitro mineralization by an osteogenic clonal cell line (C1) derived from mouse teratocarcinoma. Differentiation 53, 181, 1993.
37. Xiao, G., Cui, Y., Ducy, P., Karsenty, G., and Franceschi, R.T. Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: Requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Mol. Endocrinol. 11, 1103, 1997.
38. Beck, G.R., Jr., Zerler, B., and Moran, E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc. Natl. Acad. Sci. U.S.A. 97, 8352, 2000.
39. De Ugarte, D.A., Morizono, K., Elbarbary, A., Alfonso, Z., Zuk, P.A., Zhu, M., Dragoo, J.L., Ashjian, P., Thomas, B., Benhaim, P., Chen, I., Fraser, J., and Hedrick, M.H. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174, 101, 2003.
40. Lee, J.A., Parrett, B.M., Conejero, J.A., Laser, J., Chen, J., Kogon, A.J., Nanda, D., Grant, R.T., and Breitbart, A.S. Biological alchemy: Engineering bone and fat from fat-derived stem cells. Ann. Plast. Surg. 50, 610, 2003.
41. Ogawa, R., Mizuno, H., Watanabe, A., Migita, M., Shimada, T., and Hyakusoku, H. Osteogenic and chondrogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice. Biochem. Biophys. Res. Commun. 313, 871, 2004.
42. Zegzula, H.D., Buck, D.C., Brekke, J., Wozney, J.M., and Hollinger, J.O. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J. Bone Joint Surg. Am. 79, 1778, 1997.
43. Dragoo, J.L., Choi, J.Y., Lieberman, J.R., Huang, J., Zuk, P.A., Zhang, J., Hedrick, M.H., and Benhaim, P. Bone induction by BMP-2 transduced stem cells derived from human fat. J. Orthop. Res. 21, 622, 2003.
44. Helvering, L.M., Sharp, R.L., Ou, X., and Geiser, A.G. Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes. Gene 256, 123, 2000.
45. zur Nieden, N.I., Kempka, G., and Ahr, H.J. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 71, 18, 2003.
46. Quinn, J.M., Morfis, M., Lam, M.H., Elliott, J., Kartsogiannis, V., Williams, E.D., Gillespie, M.T., Martin, T.J., and Sexton, P.M. Calcitonin receptor antibodies in the identification of osteoclasts. Bone 25, 1, 1999.
47. Boyle, W.J., Simonet, W.S., and Lacey, D.L. Osteoclast differentiation and activation. Nature 423, 337, 2003.
48. Kaneko, H., Arakawa, T., Mano, H., Kaneda, T., Ogasawara, A., Nakagawa, M., Toyama, Y., Yabe, Y., Kumegawa, M., and Hakeda, Y. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 27, 479, 2000.
49. Itoh, K., Udagawa, N., Katagiri, T., Iemura, S., Ueno, N., Yasuda, H., Higashio, K., Quinn, J.M., Gillespie, M.T., Martin, T.J., Suda, T., and Takahashi, N. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-κB ligand. Endocrinology 142, 3656, 2001.
50. Koide, M., Murase, Y., Yamato, K., Noguchi, T., Okahashi, N., and Nishihara, T. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1α through upregulation of osteoclast differentiation factor and cyclooxygenase-2. Biochem. Biophys. Res. Commun. 259, 97, 1999.
51. Kanatani, M., Sugimoto, T., Kaji, H., Kobayashi, T., Nishiyama, K., Fukase, M., Kumegawa, M., and Chihara, K. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J. Bone Miner. Res. 10, 1681, 1995.
52. Saneshige, S., Mano, H., Tezuka, K., Kakudo, S., Mori, Y., Honda, Y., Itabashi, A., Yamada, T., Miyata, K., Hakeda, Y., et al. Retinoic acid directly stimulates osteoclastic bone resorption and gene expression of cathepsin K/OC-2. Biochem. J. 309, 721, 1995.
53. 3 stimulate osteoclast formation by different mechanisms. Bone 11, 53, 1990.
54. Hattersley, G., and Chambers, T.J. Calcitonin receptors as markers for osteoclastic differentiation: Correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures. Endocrinology 125, 1606, 1989.